Covidien wins FDA nod for battery-powered iDrive Ultra surgical stapler
Covidien lands 510(k) clearance for its iDrive Ultra Powered surgical stapling system, which the company calls the only fully powered, battery operated and reusable endoscopic stapler available worldwide.
Covidien (NYSE:COV) touted FDA clearance for its iDrive Ultra Powered surgical stapler, which the company calls the only fully powered, reusable, battery-operated endoscopic surgical stapler in the world.
The iDrive Ultra is the 2nd in Covidien's line of powered stapling devices and the 1st to fit all of the device maker's Endo GIA staple reloads, according to a press release.
"The newest addition to our line of battery-powered devices delivers optimal functionality due to the valuable feedback surgeons have provided," Covidien surgical solution chief technology officer and vice president Paul Hermes said in prepared remarks. "We work closely with surgeons to develop products that not only improve patient outcomes, but also make surgery safer, easier and more efficient for surgeons."